Abstract
P225 - Breast cancer-specific survival in 6,768 patients with lymph nodepositive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene Recurrence Score® (RS) results in the SEER registries
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have